Proton beam therapy is an advanced form of external radiotherapy that uses high-energy proton beams instead of photon x-ray beams or electrons. Carefully measured doses of protons are delivered to the precise area needing treatment, using the latest IBA ProteusONE technology. This ensures that the delivery of proton beam therapy is highly accurate and prevents the risk of radiation reaching surrounding healthy tissue.
Radiotherapy is used to kill and destroy cancer cells. It utilises radiation in the form of high-energy x-rays, known as photons, to kill and damage the cancerous cells and prevent their growth and reproduction. It can be used as a non-surgical option to treat cancer, and it can also be used to shrink a tumour or in combination with other treatments.
We provide a chemotherapy treatment service that offers you both choice and flexibility. Chemotherapy is the use of cytotoxic (anti-cancer) drugs to destroy cancer cells in the body by disrupting the cancer cells and preventing them from growing and dividing.
Here visitors can find an overview of all the consultants who work with the Rutherford Cancer Centres. Click to go through to the individual consultant biography pages where information is available on their qualifications, medical memberships, and particular cancer or body area specialisms.
Using the filter option below, consultants can be narrowed down by speciality and their closest centre. However, consultants will travel between locations should patients need or choose to receive treatment in another of our cancer centres. To find out more about our consultants’ specialities or if you’d like to message a consultant directly, please click on the relevant profiles below.
Dr Mark Verrill studied Medicine at the University of Cambridge and University College London, qualifying in 1989. He was awarded Membership of the Royal College of Physicians in 1993 and Fellowship in 2003. He trained in medical oncology at the Royal Marsden Hospital and Institute of Cancer Research, London.
Dr Verrill's first consultant appointment in 1989 was as Cancer Research UK Senior Lecturer in Medical Oncology at Newcastle University and Honorary Consultant Medical Oncologist in the Newcastle Hospitals. He moved full time into the NHS in 2007.
Dr Verrill is internationally respected for his clinical trials work in breast cancer and regarded as a "key opinion leader" with multiple publications in high impact peer-reviewed journals. He's also lectured on breast cancer all over the world. His areas of interest include Systemic therapies for Breast Cancer, HER2 positive breast cancer, ER positive breast cancer and Gastrointestinal Stromal Tumours.
American Society of Clinical Oncology
Association of Cancer Physicians
British Association for Cancer Research
Dr Mark Verrill does not hold a share or financial interest in the Rutherford Cancer Centres or another Rutherford Health plc company.
Dr Mark Verrill does not have a share or financial interest in equipment used at the Rutherford Cancer Centres or another Rutherford Health plc company.
Dr Mark Verrill does not hold any paid advisory role(s) at the Rutherford Cancer Centres or on behalf of Rutherford Cancer Centres or Rutherford Health plc.
Get in Touch
If you'd like to speak to us about any of the treatments we offer please don’t hesitate to get in touch. Call us on 0800 210 0402 or